Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

US Expects To Vaccinate 100 Million People Against Covid By February

US Expects To Vaccinate 100 Million People Against Covid By February

The push should start within weeks, when vaccines developed by Pfizer-BioNTech and Moderna-NIH are expected to be approved.
The US hopes to have immunized 100 million people against Covid-19 by the end of February, a top official said Wednesday, which is approximately 40 percent of the country's adult population.

The push should start within weeks, when vaccines developed by Pfizer-BioNTech and Moderna-NIH are expected to be approved.

Each of these require two doses, the second after three weeks and four weeks, respectively.

"Between mid-December, and the end of February, we will have potentially immunized 100 million people," Moncef Slauoi, scientific advisor to the government's Operation Warp Speed (OWS) program told reporters.

This, he continued, would cover the "at-risk" population comprising the elderly, health care workers, and first responders.

There will be an "ample" amount of vaccine to immunize three million residents of long-term care facilities, said the former pharmaceutical executive, who was recruited by the administration of President Donald Trump in May.

The rest would be enough to reach the bulk of health care workers, if states and other territories agree with federal recommendations to prioritize this population.

As production of the two vaccines expands, 20 million will be reached in December, 30 million in January and 50 million in February, making 100 million total.

This figure, however, excludes other vaccines by Johnson & Johnson and AstraZeneca-Oxford that are in the late stages of development.

Slaoui said both could produce their results between the end of December and mid-January, paving the way for emergency approval by February if the US Food and Drug Administration (FDA) gives the green light.

Slaoui added that the AstraZeneca-Oxford vaccine might be evaluated solely on the basis of a large US clinical trial involving 15,000 people, and not with data from Britain and Brazil where the data has been marred by a dosage issue.

While the Pfizer-BioNTech vaccine was approved by Britain on Wednesday, the process is slower and more public in the US.

The FDA won't grant an emergency use authorization (EUA) before a public meeting of an advisory committee is held on December 10. For the Moderna vaccine, a similar meeting will occur on December 17.

Officials say that the logistics have been put in place to start distributing the vaccines, if approved, almost right away.

"When an EUA decision comes, distribution to the American people becomes immediate within 24 hours, that's our goal," said General Gus Perna, chief operating officer of OWS.

Right now he is expecting to deliver the first doses on December 15.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×